Influence of Immunosuppression Regimen on Heart Transplantation Survival

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2550-2552

  Aguero J ^a   Almenar, L ^a   Martinez Dolz L ^a   Chamorro, C ^a   Moro, J ^a   Rueda, J ^a   Arnau, M A ^a   Zorio, E ^a   Izquierdo, M ^a   Salvador, A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TSUKUBAENOLIDE;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; LOG RANK TEST; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT DURATION;

ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 33750610155     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.080     Document Type: Article

References (6)

1. Mueller X. Drug immunosuppression therapy for adult heart transplantation. Part 2: Clinical applications and results. Ann Thorac Surg 77 (2004) 363
2. Johnson M.R., Mullen G.M., O'Sullivan E.J., et al. Risk/benefit ratio of perioperative OKT3 in cardiac transplantation. Am J Cardiol 74 (1994) 261
3. Hershberger R.E., Starling R.C., Eisen H.J., et al. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med 352 (2005) 2705
4. Mehra M.R., Zucker M.J., Wagoner L., et al. A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. J Heart Lung Transplant 24 (2005) 1297
5. Pham S.M., Kormos R.L., Hattler B.G., et al. A prospective trial of tacrolimus (FK506) in clinical heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 111 (1996) 764
6. Kobashigawa J., Miller L., Renlund D., et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 66 (1998) 507